Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism and treatment strategies of gynecological cancer-related anemia
ChiCTR-IPR-16009508Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of epoetin alfa and Iron in cancer-associated anemia (CRA) and gynecological cancer (6 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Blood routine. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
epoetin alfaIron
03
Conditions
cancer-associated anemia (CRA)gynecological cancer
Beyond the preview
Go deeper on ChiCTR-IPR-16009508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009508.